Relmada Therapeutics, Inc.(RLMD)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RLMD Relmada Therapeutics, Inc.

未开盘 11-04 16:00:00 EST

3.42

-0.07

-2.01%

盘后3.42

+0.000.00%

16:02 EST

最高3.67	最低3.36	成交量11.42万
今开3.50	昨收3.49	日振幅8.95%
总市值1.03亿	流通市值9,419万	总股本3,017万
成交额39.28万	换手率0.41%	流通股本2,754万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RLMD","market":"US","secType":"STK","nameCN":"Relmada Therapeutics, Inc.","latestPrice":3.42,"timestamp":1730754000000,"preClose":3.49,"halted":0,"volume":114159,"hourTrading":{"tag":"盘后","latestPrice":3.42,"preClose":3.42,"latestTime":"16:02 EST","volume":117,"amount":400.14,"timestamp":1730754150083},"delay":0,"floatShares":27540528,"shares":30174202,"eps":-2.88,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.07,"latestTime":"11-04 16:00:00 EST","open":3.5,"high":3.6723,"low":3.36,"amount":392779.199815,"amplitude":0.089484,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.88,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1730797200000},"adr":0,"adjPreClose":3.49,"postHourTrading":{"tag":"盘后","latestPrice":3.42,"preClose":3.42,"latestTime":"16:02 EST","volume":117,"amount":400.14,"timestamp":1730754150083},"volumeRatio":0.910973,"impliedVol":1.6978,"impliedVolPercentile":0.6096},"requestUrl":"/m/hq/s/RLMD","defaultTab":"news","newsList":[{"id":"2481565120","title":"Relmada Therapeutics Inc   预计每股亏损64美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481565120","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481565120?lang=zh_cn&edition=full","pubTime":"2024-11-05 06:20","pubTimestamp":1730758813,"startTime":"0","endTime":"0","summary":"   * Relmada Therapeutics Inc    预计在11月6日公布截至2024年9月30日的财报时，季度营收将不会有任何变化(预计)。*    * LSEG 的分析师平均预计 Relmada Therapeutics Inc 每股亏损 64 美分。* 华尔街对 Relmada Therapeutics Inc 的 12 个月目标价中位数为 11.50 美元，高于其上一次收盘价 3.49 美元。11月4日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","LENZ"],"gpt_icon":0},{"id":"2477598573","title":"Relmada Therapeutics, Inc.盘中异动 快速跳水6.47%报3.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477598573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477598573?lang=zh_cn&edition=full","pubTime":"2024-10-22 22:45","pubTimestamp":1729608355,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日22时45分，Relmada Therapeutics, Inc.股票出现波动，股价急速下跌6.47%。截至发稿，该股报3.40美元/股，成交量2.7366万股，换手率0.09%，振幅2.48%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为4212.97%、3575.74%、1923.87%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Aptevo Therapeutics Inc.、Genprex, Inc.，振幅分别为165.44%、99.41%、81.46%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022224556a1e2d34a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022224556a1e2d34a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLMD","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2475685750","title":"Relmada Therapeutics, Inc.盘中异动 快速上涨5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475685750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475685750?lang=zh_cn&edition=full","pubTime":"2024-10-15 21:36","pubTimestamp":1728999410,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日21时36分，Relmada Therapeutics, Inc.股票出现异动，股价急速上涨5.97%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Lipella Pharmaceuticals Inc.、Enveric Biosciences, Inc.、Gritstone Bio, Inc.较为活跃，换手率分别为249.50%、169.92%、144.09%，振幅较大的相关个股有Gritstone Bio, Inc.、Meiragtx Holdings Plc、Bright Minds Biosciences Inc.，振幅分别为29.63%、15.52%、14.05%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015213651971a05ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015213651971a05ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLMD","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2472952294","title":"Relmada Therapeutics, Inc.盘中异动 早盘大幅拉升8.54%报3.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472952294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472952294?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:32","pubTimestamp":1728048741,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时32分，Relmada Therapeutics, Inc.股票出现波动，股价急速上涨8.54%。截至发稿，该股报3.56美元/股，成交量1681股，换手率0.01%，振幅0.00%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Aditxt, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大，Aditxt, Inc.、Elevai Labs, Inc.、Theriva Biologics, Inc.较为活跃，换手率分别为1532.75%、16.75%、16.26%，振幅较大的相关个股有Aditxt, Inc.、Pharmacyte  Biotech, Inc.、Estrella Immunopharma, Inc.，振幅分别为16.49%、10.98%、9.01%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100421322198e3a94a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100421322198e3a94a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","RLMD"],"gpt_icon":0},{"id":"2460001085","title":"Relmada Therapeutics, Inc.盘中异动 急速下跌5.82%报2.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460001085","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460001085?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:35","pubTimestamp":1724160946,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时35分，Relmada Therapeutics, Inc.股票出现波动，股价急速下挫5.82%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Inmed Pharmaceuticals Inc.、泰坦制药、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Inmed Pharmaceuticals Inc.、泰坦制药、Alzamend Neuro, Inc.较为活跃，换手率分别为1812.93%、335.65%、191.34%，振幅较大的相关个股有Inmed Pharmaceuticals Inc.、Biomotion Sciences C/Wts Exp 15/08/2029 、泰坦制药，振幅分别为103.11%、78.89%、28.68%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820213546a1d53b6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820213546a1d53b6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLMD","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2460249071","title":"Relmada Therapeutics, Inc.2024财年第二财季实现净利润-17.77百万美元，同比增加29.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460249071","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460249071?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824030,"startTime":"0","endTime":"0","summary":"8月17日，Relmada Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-17.77百万美元，同比增加29.76%；其中营业收入为0.00美元，每股基本收益为-0.59美元。从资产负债表来看，Relmada Therapeutics, Inc.总负债9.54百万美元，其中短期债务0.00美元，资产负债比为7.45，流动比率为7.44。机构评级：截至2024年8月17日，当前有4家机构对Relmada Therapeutics, Inc.目标价做出预测，其中目标均价为10.12美元，其中最低目标价为2.00美元，最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000443959f2bde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000443959f2bde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLMD","LENZ"],"gpt_icon":0},{"id":"2459172628","title":"Relmada Therapeutics, Inc.盘中异动 早盘急速拉升6.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459172628","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459172628?lang=zh_cn&edition=full","pubTime":"2024-08-14 21:36","pubTimestamp":1723642580,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日21时36分，Relmada Therapeutics, Inc.股票出现波动，股价急速上涨6.69%。截至发稿，该股报2.71美元/股，成交量2188股，换手率0.01%，振幅0.00%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Conduit Pharmaceuticals Inc.、Cormedix Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Genprex, Inc.、Conduit Pharmaceuticals Inc.、Viracta Therapeutics, Inc.较为活跃，换手率分别为57.22%、55.32%、44.43%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Genprex, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为44.00%、41.17%、17.45%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814213620ab5daf21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814213620ab5daf21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","RLMD"],"gpt_icon":0},{"id":"2459901775","title":"Relmada Therapeutics, Inc.盘中异动 早盘股价大涨7.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459901775","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459901775?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:47","pubTimestamp":1723556822,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时47分，Relmada Therapeutics, Inc.股票出现异动，股价大幅拉升7.39%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、冠科美博涨幅较大，Genprex, Inc.、冠科美博、Oragenics Inc.较为活跃，换手率分别为120.16%、82.92%、19.89%，振幅较大的相关个股有冠科美博、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为45.17%、33.11%、32.58%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081321470295957796&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081321470295957796&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","RLMD"],"gpt_icon":0},{"id":"2458964455","title":"Relmada Therapeutics, Inc.盘中异动 早盘股价大涨17.39%报2.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458964455","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458964455?lang=zh_cn&edition=full","pubTime":"2024-08-09 21:32","pubTimestamp":1723210333,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日21时32分，Relmada Therapeutics, Inc.股票出现波动，股价大幅上涨17.39%。截至发稿，该股报2.70美元/股，成交量7446股，换手率0.02%，振幅9.57%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Adma Biologics Inc、Third Harmonic Bio, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Cns Pharmaceuticals, Inc.、Aditxt, Inc.较为活跃，换手率分别为33.26%、5.41%、5.16%，振幅较大的相关个股有An2 Therapeutics, Inc.、Avidity Biosciences, Inc.、Brainstorm Cell Therapeutics Inc.，振幅分别为10.74%、10.46%、10.21%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213213958bfe0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213213958bfe0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RLMD","BK4007","LENZ"],"gpt_icon":0},{"id":"2457631917","title":"Relmada Therapeutics, Inc.盘中异动 早盘快速跳水5.86%报3.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457631917","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457631917?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:34","pubTimestamp":1723124063,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日21时34分，Relmada Therapeutics, Inc.股票出现异动，股价快速下跌5.86%。截至发稿，该股报3.05美元/股，成交量937股，换手率0.00%，振幅1.54%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，Conduit Pharmaceuticals Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Anew Medical, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Aditxt, Inc.较为活跃，换手率分别为190.07%、189.10%、46.03%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Generation Bio Co.，振幅分别为39.15%、18.35%、14.41%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808213423941ff736&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808213423941ff736&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RLMD","LENZ","BK4007"],"gpt_icon":0},{"id":"2456402342","title":"Relmada Therapeutics Inc    预计每股亏损 83 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456402342","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456402342?lang=zh_cn&edition=full","pubTime":"2024-08-02 19:52","pubTimestamp":1722599559,"startTime":"0","endTime":"0","summary":"   * Relmada Therapeutics Inc    将于8月6日公布截至2024年6月30日的财报() 预计季度营收将保持不变。*    * LSEG 的分析师平均预计 Relmada Therapeutics Inc 每股亏损 83 美分。* 华尔街对 Relmada Therapeutics Inc 的 12 个月目标价中位数为 7.75 美元，高于其上一次收盘价 3.69 美元。8月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","LENZ"],"gpt_icon":0},{"id":"2455155783","title":"Relmada Therapeutics, Inc.盘中异动 快速下跌6.82%报3.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455155783","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455155783?lang=zh_cn&edition=full","pubTime":"2024-07-31 23:18","pubTimestamp":1722439104,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日23时18分，Relmada Therapeutics, Inc.股票出现异动，股价快速跳水6.82%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。其相关个股中，Renovaro Inc.、Zevra Therapeutics, Inc.、Applied Therapeutics, Inc.涨幅较大，Bionomics Ltd Ads Each Rep 180 Ord Shs、Salarius Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为137.45%、130.84%、125.52%，振幅较大的相关个股有Renovaro Inc.、Alpha Tau Medical Ltd C/Wts 、Salarius Pharmaceuticals, Inc.，振幅分别为79.10%、44.12%、40.61%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731231825aefc7d4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731231825aefc7d4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","RLMD"],"gpt_icon":0},{"id":"2453058308","title":"Relmada Therapeutics, Inc.盘中异动 早盘急速跳水5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453058308","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453058308?lang=zh_cn&edition=full","pubTime":"2024-07-23 21:48","pubTimestamp":1721742491,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日21时48分，Relmada Therapeutics, Inc.股票出现异动，股价快速下挫5.31%。截至发稿，该股报3.92美元/股，成交量1.5146万股，换手率0.05%，振幅2.90%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Adial Pharmaceuticals, Inc、Salarius Pharmaceuticals, Inc.、Kiniksa Pharmaceuticals, Ltd.涨幅较大，Adial Pharmaceuticals, Inc、Salarius Pharmaceuticals, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为1460.89%、79.12%、78.84%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Salarius Pharmaceuticals, Inc.、Anew Medical, Inc.，振幅分别为94.31%、43.40%、20.98%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723214811af93aab2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723214811af93aab2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","RLMD","LENZ"],"gpt_icon":0},{"id":"2453799943","title":"Relmada Therapeutics, Inc.盘中异动 股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453799943","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453799943?lang=zh_cn&edition=full","pubTime":"2024-07-22 22:27","pubTimestamp":1721658434,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日22时27分，Relmada Therapeutics, Inc.股票出现异动，股价快速跳水5.63%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Apollomics Inc C/Wts 01/04/2028 、木薯科学涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为111.67%、97.09%、30.30%，振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、木薯科学、Hepion Pharmaceuticals, Inc.，振幅分别为44.07%、32.04%、27.45%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222227149681ee9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222227149681ee9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","RLMD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.relmada.com","stockEarnings":[{"period":"1week","weight":-0.0359},{"period":"1month","weight":0.0265},{"period":"3month","weight":-0.0306},{"period":"6month","weight":-0.0516},{"period":"1year","weight":0.1443},{"period":"ytd","weight":-0.157}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.1169},{"period":"1year","weight":0.3257},{"period":"ytd","weight":0.2014}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Relmada Therapeutics, Inc.是私人控股公司，于2004年5月注册成立。该公司是一家临床阶段的生物制药公司，致力于开发用于治疗慢性疼痛的候选药物。该公司专注于开发d-methadone（右美沙酮，REL-1017），一种N-甲基-D-天冬氨酸（NMDA）受体拮抗剂。美沙酮是一种新的化学实体，可能解决中枢神经系统（CNS）疾病和其他疾病治疗中未满足医疗需求的领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.047507},{"month":2,"riseRate":0.666667,"avgChangeRate":0.107392},{"month":3,"riseRate":0.5,"avgChangeRate":-0.035153},{"month":4,"riseRate":0.666667,"avgChangeRate":0.029344},{"month":5,"riseRate":0.428571,"avgChangeRate":0.009291},{"month":6,"riseRate":0.142857,"avgChangeRate":-0.112899},{"month":7,"riseRate":0.714286,"avgChangeRate":0.090315},{"month":8,"riseRate":0.428571,"avgChangeRate":0.000624},{"month":9,"riseRate":0.857143,"avgChangeRate":0.103955},{"month":10,"riseRate":0.428571,"avgChangeRate":0.103531},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.059583},{"month":12,"riseRate":0.5,"avgChangeRate":0.132279}],"exchange":"NASDAQ","name":"Relmada Therapeutics, Inc.","nameEN":"Relmada Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Relmada Therapeutics, Inc.(RLMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Relmada Therapeutics, Inc.(RLMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Relmada Therapeutics, Inc.,RLMD,Relmada Therapeutics, Inc.股票,Relmada Therapeutics, Inc.股票老虎,Relmada Therapeutics, Inc.股票老虎国际,Relmada Therapeutics, Inc.行情,Relmada Therapeutics, Inc.股票行情,Relmada Therapeutics, Inc.股价,Relmada Therapeutics, Inc.股市,Relmada Therapeutics, Inc.股票价格,Relmada Therapeutics, Inc.股票交易,Relmada Therapeutics, Inc.股票购买,Relmada Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Relmada Therapeutics, Inc.(RLMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Relmada Therapeutics, Inc.(RLMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况